Ligand Pharmaceuticals Inc logo

Ligand Pharmaceuticals Inc

NEW
STU:LGDN (USA)   Ordinary Shares - Class B
€ 262 +2 (+0.77%) Aug 6
42.13
P/B:
6.22
Market Cap:
€ 5.20B ($ 6.00B)
Enterprise V:
€ 4.91B ($ 5.68B)
Volume:
0
Avg Vol (2M):
112.00
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

AAPL Stock Intrinsic Values - Apple Inc